The effect of using three anesthesia methods with propofol, sevoflurane, and dexmedetomidine on respiratory complications in children aged 1 month to 3 years undergoing fiber optic bronchoscopy.

Comparative study of the effect of using three anesthesia methods with propofol, sevoflurane, and dexmedetomidine on respiratory complications in children aged 1 month to 3 years undergoing fiber optic bronchoscopy.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200825048515N69

Enrollment

120

Registered

2023-06-18

Start date

2023-07-21

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fiber optic bronchoscopy.

Interventions

Intervention 1: First intervention group: patients in this group are under anesthesia with inhaled sevoflurane. In this way, they are first induced with 2 MAC and after deepening the anesthesia, they

Eligibility

Sex/Gender

All

Age

1 Months to 3 Years

Inclusion criteria

Inclusion criteria: Children from 1 month to 3 years Candidate for diagnostic fiber optic bronchoscopy ASA equal to I or II Consent to participate in the study

Exclusion criteria

Exclusion criteria: Having comorbidity (Such as heart disease, metabolic disease, history of seizures, high ICP, porphyria, thyroid disease) Therapeutic bronchoscopy (presence of foreign body, etc.)

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: upon entering the operating room, and every 5 minutes during bronchoscopy and every 15 minutes during recovery until the end of recovery. Method of measurement: Monitoring device.;Heart beat. Timepoint: upon entering the operating room, and every 5 minutes during bronchoscopy and every 15 minutes during recovery until the end of recovery. Method of measurement: Monitoring device.;Oxygen saturation (SpO2). Timepoint: upon entering the operating room, and every 5 minutes during bronchoscopy and every 15 minutes during recovery until the end of recovery. Method of measurement: Monitoring device.;Respiratory complications. Timepoint: During bronchoscopy. Method of measurement: Observation.	—

Measure

Time frame

Blood pressure. Timepoint: upon entering the operating room, and every 5 minutes during bronchoscopy and every 15 minutes during recovery until the end of recovery. Method of measurement: Monitoring device.;Heart beat. Timepoint: upon entering the operating room, and every 5 minutes during bronchoscopy and every 15 minutes during recovery until the end of recovery. Method of measurement: Monitoring device.;Oxygen saturation (SpO2). Timepoint: upon entering the operating room, and every 5 minutes during bronchoscopy and every 15 minutes during recovery until the end of recovery. Method of measurement: Monitoring device.;Respiratory complications. Timepoint: During bronchoscopy. Method of measurement: Observation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Shafa

Esfahan University of Medical Sciences

shafa_amir@yahoo.com+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026